The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
128006561 12800656 1 I 20160704 20160915 20160930 20160930 EXP US-BAUSCH-BL-2016-023843 BAUSCH AND LOMB 0.00 E F Y 0.00000 20160930 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
128006561 12800656 1 PS ALBUTEROL. ALBUTEROL 1 1 AS NECESSARY 75050 180 UG
128006561 12800656 2 SS AZELASTINE HYDROCHLORIDE. AZELASTINE HYDROCHLORIDE 1 Nasal 0 NASAL SPRAY, SOLUTION
128006561 12800656 3 SS EYLEA AFLIBERCEPT 1 Intraocular RIGHT EYE, ONCE MONTHLY FOR 3 INJECTIONS THEN EVERY 2 MONTHS Y 0 2 MG INJECTION
128006561 12800656 4 SS EYLEA AFLIBERCEPT 1 Intraocular RIGHT EYE, ONCE MONTHLY FOR 3 INJECTIONS THEN EVERY 2 MONTHS Y 0 2 MG INJECTION
128006561 12800656 5 SS EYLEA AFLIBERCEPT 1 Intraocular RIGHT EYE, ONCE MONTHLY FOR 3 INJECTIONS THEN EVERY 2 MONTHS Y 0 2 MG INJECTION
128006561 12800656 6 SS GABAPENTIN. GABAPENTIN 1 Unknown Y 0 QD
128006561 12800656 7 SS GABAPENTIN. GABAPENTIN 1 Y 0
128006561 12800656 8 SS FLONASE FLUTICASONE PROPIONATE 1 Nasal 0 NASAL SPRAY
128006561 12800656 9 SS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 Unknown 0 10 MG QD
128006561 12800656 10 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown 0 2 DF BID
128006561 12800656 11 SS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 0 QD
128006561 12800656 12 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Unknown 0 10 MG QD
128006561 12800656 13 C LOSARTAN POTASSIUM W/HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 Unknown 0
128006561 12800656 14 C ZETIA EZETIMIBE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
128006561 12800656 1 Asthma
128006561 12800656 2 Asthma
128006561 12800656 3 Neovascular age-related macular degeneration
128006561 12800656 6 Spinal column stenosis
128006561 12800656 8 Asthma
128006561 12800656 9 Asthma
128006561 12800656 10 Asthma
128006561 12800656 11 Asthma
128006561 12800656 12 Asthma
128006561 12800656 13 Product used for unknown indication
128006561 12800656 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
128006561 12800656 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
128006561 12800656 Asthma
128006561 12800656 Drug ineffective for unapproved indication
128006561 12800656 Eosinophil count increased
128006561 12800656 Off label use
128006561 12800656 Pulmonary function test decreased
128006561 12800656 Transient ischaemic attack

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
128006561 12800656 3 20160524 20160524 0
128006561 12800656 4 20160621 20160621 0
128006561 12800656 5 20160719 20160719 0
128006561 12800656 6 201601 201602 0
128006561 12800656 7 20160703 201607 0